Briarfield beats WCCA for fourth MAIS state title in eight years

Florida State continues torrid star with rout of UMassQuanterix Announces Receipt of Expected Notice from NasdaqThe top Australian artificial intelligence (AI) shares to buy for 2025

BILLERICA, Mass.--(BUSINESS WIRE)--Nov 22, 2024-- Quanterix Corporation (NASDAQ: QTRX) today announced that it received a notice (the “Notice”) on November 21, 2024 from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company has not yet filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the “Form 10-Q"), it is no longer in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the “SEC”). The Notice has no immediate effect on the listing or trading of the Company’s common stock on Nasdaq. Under Nasdaq rules, the Company has 60 calendar days from receipt of the Notice, or until January 20, 2025, to submit a plan to regain compliance with the Rule. On November 12, 2024, the Company previously announced that it would be delayed in filing the Form 10-Q due to the need to restate the Company’s audited consolidated financial statements as of December 31, 2023 and 2022 and for each of the three years in the period ended December 31, 2023, and its unaudited consolidated financial statements for the quarterly and year-to-date (as applicable) periods ended March 31, 2022, June 30, 2022, September 30, 2022, March 31, 2023, June 30, 2023, September 30, 2023, March 31, 2024 and June 30, 2024. The Notice from Nasdaq is standard practice in the event of a delayed periodic financial report filing and was anticipated. The Company is continuing to work expeditiously to complete the filing of the Form 10-Q and remains on track to complete the restatement and all required filings by the end of 2024. This announcement is made in compliance with Nasdaq Listing Rule 5250(b)(2). About Quanterix From discovery to diagnostics, Quanterix’s ultrasensitive biomarker detection is fueling breakthroughs only made possible through its unparalleled sensitivity and flexibility. The Company’s Simoa ® technology has delivered the gold standard for earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the Level of Quantification (LoQ). Its industry-leading precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Quanterix has been a trusted partner of the scientific community for nearly two decades, powering research published in more than 3,100 peer-reviewed journals. Find additional information about the Billerica, Massachusetts-based company at https://www.quanterix.com or follow us on Twitter and LinkedIn . Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “may,” “will,” “expect,” “plan,” “anticipate,” “estimate,” “intend” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. Forward-looking statements in this press release are based on Quanterix’s expectations and assumptions as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties. Factors that may cause Quanterix’s actual results to differ from those expressed or implied in the forward-looking statements in this press release include, but are not limited to, that the Company may have underestimated the scope and impact of the restatement of certain of its financial statement and the risk that the Company’s restated financial statements may take longer to complete than expected, as well as those described in our periodic reports filed with the U.S. Securities and Exchange Commission, including the “Risk Factors” sections contained therein. Except as required by law, Quanterix assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available. View source version on businesswire.com : https://www.businesswire.com/news/home/20241122959546/en/ CONTACT: Media: media@quanterix.comInvestor Relations: Amy Achorn (978) 488-1854 ir@quanterix.com KEYWORD: MASSACHUSETTS UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH TECHNOLOGY HEALTH MEDICAL DEVICES SOURCE: Quanterix Corporation Copyright Business Wire 2024. PUB: 11/22/2024 05:00 PM/DISC: 11/22/2024 05:02 PM http://www.businesswire.com/news/home/20241122959546/enI'm A Celebrity...Get Me Out Of Here! stalwart Barry McGuigan has recounted a harrowing tale of his boxing days, detailing how an injury led to a complete nose reconstruction with plastic. In the gripping episode on Friday (November 22), sporting legends and celebrities alike huddled together for an intimate conversation about their ties to boxing. Coleen Rooney kicked off the banter, divulging her childhood pastime to Barry and pop sensation Danny Jones from McFly. With a nostalgic edge, she shared: "My dad had us, me and my two brothers sparring each other when we were younger. "He used to get us in the living room, we've got it all on video. I was Big Betty, my brother's called Jo and he was Little Josie, and we used to have a ring walk." Then came McGuigan's striking revelation as the 63 year old ex-champion discussed how a grievous blow transformed his appearance, disclosing: "When I had it broken it was flat, so they just took the bone out and replaced it with plastic." Launching his career in the squared circle back in 1981, Barry McGuigan's boxing journey is marked by glory - reigning supreme as both British and European featherweight champion from 1983 through to 1985. Moreover, this Irish legend clinched his place amongst the immortals in the International Boxing Hall of Fame in 2005. Seizing the chance for a masterclass, Danny eagerly sought McGuigan's advice on mastering body shots. Generously obliging, Barry cheerfully engaged in an exchange of friendly punches with Danny, who managed a swift quintet of strikes on the seasoned fighter. Later on the show, the singer exclaimed to the Bush Telegraph: "Today my life was made because Barry McGuigan let me hit him in the stomach. I hit him really hard and it was solid, it was like hitting a brick wall." As the eldest participant in this year's cast, Barry had expressed his belief that he would serve as a pillar of serenity among the younger members. Prior to venturing into the wilderness, he commented: "I'm the consoler when the guys have a hard day in the gym and they haven't sparred particularly well." He added with a touch of uncertainty, "I'd like to think I'd be someone who would act as a 'calmer downer' if you like. Or I might get irritated. I really don't know." I’m A Celebrity...Get Me Out Of Here! returns tomorrow at 9pm on ITV1 and ITVX

None